Protection of islets of Langerhans from antibodies by microencapsulation with alginate-poly-L-lysine membranes.
Microencapsulation of islets has been proposed to prevent their immune destruction following transplantation. An indirect immunofluorescence technique has been developed and used to study the permeability of the alginate-poly-L-lysine microcapsules to antibodies. Wistar rat islets were incubated with the R2D6 monoclonal mouse IgM antibody against rat islets, microencapsulated, and incubated with fluorescein-labeled goat IgG antibodies against mouse IgG and IgM. For the negative controls, the first antibody was omitted or both antibodies were omitted. The positive controls included islets incubated with both antibodies before they were encapsulated. Our study demonstrated that the alginate-poly-L-lysine membranes are not permeable to IgG when poly-L-lysine of molecular weights ranging from 21,000 to 390,000 are used. This simple immunofluorescence technique demonstrated the nonpermeability of the microcapsules to IgG, and could be useful for the initial evaluation of new types of membranes.
Hallé
J P
JP
Maisonneuve-Rosemont Hospital Research Center, Montreal, Quebec, Canada.
Bourassa
S
S
Leblond
F A
FA
Chevalier
S
S
Beaudry
M
M
Chapdelaine
A
A
Cousineau
S
S
Saintonge
J
J
Yale
J F
JF
D000464:Alginates; D000818:Animals; D000906:Antibodies / Q000378:metabolism*; D066298:In Vitro Techniques; D007515:Islets of Langerhans / Q000166:cytology / Q000276:immunology*; D016381:Islets of Langerhans Transplantation; D008567:Membranes, Artificial; D051379:Mice; D008970:Molecular Weight; D010539:Permeability; D011107:Polylysine; D051381:Rats; D017208:Rats, Wistar
D000464:Alginates; D000906:Antibodies; D008567:Membranes, Artificial; D011107:Polylysine